Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Clinical Medicine
  4. Vol 4, Issue 9, 2023

Correlation of imaging markers of cerebral small vessel disease with left ventricular disease: A review

Download as PDF

DOI: 10.23977/medsc.2023.040911 | Downloads: 14 | Views: 301

Author(s)

Qing He 1, Meiru Yi 1, Hui Zhang 2

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China
2 Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712000, China

Corresponding Author

Hui Zhang

ABSTRACT

Cerebral small vessel disease (CSVD) is a combination of disorders that affects the small arteries, veins, and microvessels of the brain. It can be observed on cranial magnetic resonance imaging as cerebral white matter hyperintensity, enlarged perivascular spaces, cerebral microbleeds, cerebral atrophy, and lacunes. The underlying mechanisms of cerebral small vessel disease remain unclear. Recent studies have suggested that left ventricle-associated diseases can contribute to a better understanding of the pathogenesis of cerebral small-vessel disease. Epidemiologic and clinicopathologic data have uncovered evidence of a relationship between cerebral small vessel disease and left ventricular disease. The purpose of this paper is to explore the complex relationship between cerebral small vessel disease and left ventricular disease. Defining the relationship between cerebral small vessel disease and left ventricular-related diseases is crucial for early prevention of cerebral small vessel disease.

KEYWORDS

Cerebral small vessel disease, imaging markers, left ventricular diastolic dysfunction, ejection fraction

CITE THIS PAPER

Qing He, Meiru Yi, Hui Zhang, Correlation of imaging markers of cerebral small vessel disease with left ventricular disease: A review. MEDS Clinical Medicine (2023) Vol. 4: 77-82. DOI: http://dx.doi.org/10.23977/medsc.2023.040911.

REFERENCES

[1] Wenli Hu, Lei Yang, Xuanting Li,et al. Chinese Consensus on Diagnosis and Therapy of Cerebral Small Vessel Disease 2021[J].Chinese Journal of Stroke,2021,16(07):716-726.
[2] Thrippleton, Michael J., Backes, Walter H., et al. Quantifying blood-brain barrier leakage in small vessel disease: Review and consensus recommendations. Alzheimer's & dementia: the journal of the Alzheimer's Association, 2019, 15(6):840-858.
[3] Jia R, Solé-Guardia G, Kiliaan A J. Blood-brain barrier pathology in cerebral small vessel disease [J]. Neural Regeneration Research, 2024, 19(6): 1233-1240.
[4] Debette S, Schilling S, Duperron M G, et al. Clinical significance of magnetic resonance imaging markers of vascular brain injury: a systematic review and meta-analysis[J]. JAMA neurology, 2019, 76(1): 81-94.
[5] Blanco P J, Müller L O, Spence J D. Blood pressure gradients in cerebral arteries: a clue to pathogenesis of cerebral small vessel disease[J]. Stroke and vascular neurology, 2017: svn-2017-000087.
[6] Wu S, Wu B O, Liu M, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management [J]. The Lancet Neurology, 2019, 18(4): 394-405.
[7] Duering M, Biessels G J, Brodtmann A, et al. Neuroimaging standards for research into small vessel disease—advances since 2013[J]. The Lancet Neurology, 2023, 22(7): 602-618.
[8] Ching S M, Chia Y C, Azman W A W. Prevalence and determinants of left ventricular hypertrophy in hypertensive patients at a primary care clinic[J]. Malaysian family physician: the official journal of the Academy of Family Physicians of Malaysia, 2012, 7(2-3): 2.
[9] Cuspidi C, Sala C, Negri F, et al. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies [J]. Journal of human hypertension, 2012, 26(6): 343-349.
[10] Bonow RO, Carabello BA, Chatterjee K, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008 Sep 23; 52(13):e1-142.
[11] Kosmala W, Marwick T H. Asymptomatic left ventricular diastolic dysfunction: predicting progression to symptomatic heart failure[J]. JACC: Cardiovascular Imaging, 2020, 13(1 Part 2): 215-227.
[12] Wardlaw J M, Smith E E, Biessels G J, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration[J]. The Lancet Neurology, 2013, 12(8): 822-838.
[13] Zile M R, Brutsaert D L. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function[J]. Circulation, 2002, 105(11): 1387-1393.
[14] Johansen M C, Shah A M, Lirette S T, et al. Associations of echocardiography markers and vascular brain lesions: the ARIC Study[J]. Journal of the American Heart Association, 2018, 7(24): e008992.
[15] Muscari A, Puddu G M, Fabbri E, et al. Factors predisposing to small lacunar versus large non-lacunar cerebral infarcts: is left ventricular mass involved?[J]. Neurological Research, 2013, 35(10): 1015-1021.
[16] Brandts A, van Elderen S G C, Westenberg J J M, et al. Association of aortic arch pulse wave velocity with left ventricular mass and lacunar brain infarcts in hypertensive patients: assessment with MR imaging [J]. Radiology, 2009, 253(3): 681-688.
[17] Duprez D A. Is vascular stiffness a target for therapy? [J]. Cardiovascular drugs and therapy, 2010, 24: 305-310.
[18] Nam K W, Kwon H M, Kim H L, et al. Left ventricular ejection fraction is associated with small vessel disease in ischaemic stroke patients[J]. European journal of neurology, 2019, 26(5): 747-753.
[19] Ye K, Tao W, Wang Z, et al. Echocardiographic correlates of MRI imaging markers of cerebral small-vessel disease in patients with atrial-fibrillation-related ischemic stroke[J]. Frontiers in Neurology, 2023, 14: 1137488.
[20] Smirnov M, Destrieux C, Maldonado I L. Cerebral white matter vasculature: still uncharted?[J]. Brain, 2021, 144(12): 3561-3575.
[21] Lee W J, Jung K H, Ryu Y J, et al. Echocardiographic index E/e’in association with cerebral white matter hyperintensity progression[J]. PloS one, 2020, 15(7): e0236473.
[22] Nomoto K, Hirashiki A, Ogama N, et al. Septal E/e′ Ratio Is Associated With Cerebral White Matter Hyperintensity Progression in Young-Old Hypertensive Patients[J]. Circulation Reports, 2023, 5(2): 38-45.
[23] Wardlaw J M, Valdés Hernández M C, Muñoz‐Maniega S. What are white matter hyperintensities made of? Relevance to vascular cognitive impairment[J]. Journal of the American Heart Association, 2015, 4(6): e001140.
[24] Gouw A A, Seewann A, Van Der Flier W M, et al. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. Journal of neurology, neurosurgery, and psychiatry, 2010, 82(2):126-135.
[25] Nagaraja N, Farooqui A, Albayram M S. Association of deep white matter hyperintensity with left ventricular hypertrophy in acute ischemic stroke[J]. Journal of Neuroimaging, 2022, 32(2): 268-272.
[26] Papadopoulos A, Palaiopanos K, Protogerou A P, et al. Left ventricular hypertrophy and cerebral small vessel disease: a systematic review and meta-analysis[J]. Journal of Stroke, 2020, 22(2): 206.
[27] Charidimou A, Boulouis G, Frosch M P, et al. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study[J]. The Lancet Neurology, 2022, 21(8): 714-725.
[28] Watanabe T, Kanzaki Y, Yamauchi Y, et al. Increased prevalence of cerebral microbleeds in patients with low left ventricular systolic function[J]. Heart and Vessels, 2020, 35: 384-390.
[29] Watanabe T, Kanzaki Y, Yokoyama R, et al. Prevalence and Risk Factors of Silent Brain Microbleeds in Patients with Severe Valvular Heart Disease[J]. Circulation, 2021, 144(Suppl_1): A10971-A10971.
[30] Kang K, Lee S H, Kim B J, et al. Correlations between left ventricular mass index and cerebrovascular lesion[J]. Central European Journal of Medicine, 2011, 6: 320-330.
[31] Francis F, Ballerini L, Wardlaw J M. Perivascular spaces and their associations with risk factors, clinical disorders and neuroimaging features: a systematic review and meta-analysis[J]. International Journal of Stroke, 2019, 14(4): 359-371.
[32] Del Brutto O H, Mera R M, Atahualpa Project Investigators. Enlarged basal ganglia perivascular spaces are associated with pulsatile components of blood pressure[J]. European Neurology, 2018, 79(1-2): 86-89.
[33] Kulesh A A , Kaileva N A , Gorst N K ,et al.A relationship between the integrated assessment of magnetic resonance imaging markers for cerebral small vessel disease and the clinical and functional status in the acute period of ischemic stroke[J].IMA Press, LLC, 2018.DOI:10.14412/2074-2711-2018-1-24-31.
[34] Patel S, Patel S K, Khlif M S, et al. A15943 Cerebral atrophy in patients with type 2 diabetes and left ventricular hypertrophy: preliminary data from the Diabetes and Dementia (D2) study[J]. Journal of Hypertension, 2018, 36: e237.
[35] Bermudez Noguera C, Kerley C I, Ramadass K, et al. Deep Learning Identification of Brain Structural Atrophy Associated With Heart Failure With Preserved Ejection Fraction Among Patients With Preexisting Dementia Using Clinical Imaging[J]. Circulation, 2020, 142(Suppl_3): A13948-A13948.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 4575
Visits: 198174

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.